Advanced search
Publication Cover
Current Eye Research Volume 42, 2017 - Issue 7
Submit an article Journal homepage
521
Views
16
CrossRef citations to date
0
Altmetric
Retina

Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents

Elad MoisseievDepartment of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USACorrespondence[email protected]
View further author information
,
Jolene RudellDepartment of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USAView further author information
,
Eric V. TieuDepartment of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USAView further author information
&
Glenn YiuDepartment of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USAView further author information
Pages 1059-1063 | Received 01 Jul 2016, Accepted 17 Dec 2016, Published online: 17 Mar 2017

References

  • Pearce W, Hsu J, Yeh S. Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol 2015;26:233–239.
  • Campbell RJ, Bronskill SE, Bell CM, Paterson JM, Whitehead M, Gill SS. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol 2010;128:359–362.
  • Peyman GA. Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29:875–912.
  • Sampat KM, Wolfe JD, Shah MK, Garg SJ. Accuracy and reproducibility of seven brands of small-volume syringes used for intraocular drug delivery. Ophthalmic Surg Lasers Imaging Retina 2013;44:385–389.
  • Meyer CH, Liu Z, Brinkmann C, Rodrigues EB, Helb HM. Accuracy, precision and repeatability in preparing the intravitreal dose with a 1.0-cc syringe. Acta Ophthalmol 2012;90:e165–e166.
  • De Stefano VS, Abechain JJ, de Almeida LF, Verginassi DM, Rodrigues EB, Freymuller E, Maia M, Magalhaes O, Nguyen QD, Farah ME. Experimental investigation of needles, syringes and techniques for intravitreal injections. Clin Exp Ophthalmol 2011;39:236–242.
  • Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, DʼAmico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina 2014;34 Suppl 12:S1–S18.
  • Malik D, Tarek M, Caceres del Carpio J, Ramirez C, Boyer D, Kenney MC, Kuppermann BD. Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. Br J Ophthalmol 2014;98 Suppl 1:i11–i16.
  • Yiu G, Manjunath V, Chiu SJ, Farsiu S, Mahmoud TH. Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema. Am J Ophthalmol 2014;158:745–751.
  • Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF; Comparison of age-related macular degeneration treatments trials research group. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2015;122:809–816.
  • Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF; CATT Research Group. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2014;121:150–161.
  • Ho AC, Busbee BG, Regillo CD, Wieland MR, Van Everen SA, Li Z, Rubio RG, Lai P; HARBOR Study Group. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 2014 Nov;121(11):2181–2192.
  • Souied E, Nghiem-Buffet S, Leteneux C, Bayer S, Derveloy A, Sagkriotis A, Becker G, Cohen SY. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures. Eur J Ophthalmol 2015;25:529–534.
  • Pereboom M, Becker ML, Amenchar M, Verweij SL, van der Hoeven RT, Mulder IJ. Stability assessment of repackaged bevacizumab for intravitreal administration. Int J Pharm Compd 2015;19:70–72.
  • Yannuzzi NA, Klufas MA, Quach L, Beatty LM, Kaminsky SM, Crystal RG, D’Amico DJ, Kiss S. Evaluation of compounded bevacizumab prepared for intravitreal injection. JAMA Ophthalmol 2015;133:32–39.
  • Iezzi R. Factors influencing dose accuracy and variation of anti-VEGF drug injections. ASRS 2015 Annual Meeting.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.